Sinohealth Technology Holdings Limited announced plans to replace its fourth amended and restated memorandum and articles of association with a fifth version.
The proposed changes aim to: 1. Align the governing documents with updated Hong Kong regulations on hybrid shareholder meetings, electronic voting and digital dissemination of corporate communications. 2. Implement consequential and housekeeping revisions.
Implementation of the new memorandum and articles (New M&A) requires shareholder approval by special resolution at an upcoming general meeting. A circular outlining the full text of the amendments, the meeting notice and proxy form will be released on the company’s and HKEXnews websites in due course.
Board composition on the announcement date (27 March 2026) is as follows: • Executive Directors: Wu Yushu (Chairman), Wang Lifang • Non-executive Director: Fu Haitao • Independent Non-executive Directors: Wang Danzhou, Chui Hoi Yam, Wei Bin
Comments